Skip to main content
. 2017 Sep 21;7:12084. doi: 10.1038/s41598-017-12360-0

Figure 3.

Figure 3

Ex vivo expansion of G-CSF mobilized CD34+ HSPCs treated for 5 days with HDACIs. (a) Representative flow-cytometry analysis of CD34 and CD90 expression after 5 d of ex vivo HDACI treatment. (b) Absolute cell numbers of CD34+ cells. (c) Absolute cell numbers of CD34+CD90+ cells. Both CD34+ and CD34+CD90+ cells were significantly increased after 5 days treatment with VPA (1 mM), resminostat (1.5 µM) or entinostat (1.5 µM) compared to controls (PBS and DMSO; n = 5). Data are shown as mean ± SD, ***p < 0.001.